1. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model
- Author
-
Selim Demirtaş, Mehmet Türkyılmaz, Fevzi Sefa Dereköy, Sema Uysal, Hakan Turkon, Turan Karaca, Oğuz Güçlü, and Medine Kara
- Subjects
Male ,Antioxidant ,medicine.medical_treatment ,Apoptosis ,Signal-To-Noise Ratio ,medicine.disease_cause ,Antioxidants ,Random Allocation ,chemistry.chemical_compound ,0302 clinical medicine ,030223 otorhinolaryngology ,Saline ,Hesperetin ,General Medicine ,Immunohistochemistry ,Cochlea ,030220 oncology & carcinogenesis ,Anesthesia ,Spiral Ganglion ,Injections, Intraperitoneal ,medicine.drug ,medicine.medical_specialty ,Otoacoustic Emissions, Spontaneous ,Intraperitoneal injection ,Antineoplastic Agents ,03 medical and health sciences ,Ototoxicity ,Internal medicine ,In Situ Nick-End Labeling ,medicine ,Animals ,Rats, Wistar ,Hearing Loss ,Cell Proliferation ,Cisplatin ,business.industry ,Hesperidin ,medicine.disease ,Rats ,Disease Models, Animal ,Oxidative Stress ,Endocrinology ,Otorhinolaryngology ,chemistry ,Ear, Inner ,Pediatrics, Perinatology and Child Health ,business ,Oxidative stress - Abstract
Objectives We aimed to investigate the effects of hesperetin as a flavanon both histopathologically and immunohistochemically on cochlear apoptosis in a rat model of cisplatin-induced ototoxicity (CIO). The evaluation of the effects of hesperetin on cisplatin-induced hearing loss was performed using distortion product otoacoustic emission (DPOAE). Methods Twenty-eight wistar albino rats were used in the current study. The rats were randomly divided into four groups with seven rats in each group. Group C was exposed to a single dose of cisplatin (12 mg/kg) by intraperitoneal injection. Group CH received intraperitoneally cisplatin (12 mg/kg) and hesperetin (20 mg/kg). Group H was exposed to hesperetin (20 mg/kg) intraperitoneally. The sham group (group S) received normal saline (6 cc) intraperitoneally. The measurements of DPOAE and signal-noise ratios (SNR) were performed before the treatment and again on the first and 6 days after administration of the drugs. Rats were sacrificed and cochleae were dissected 10 days after drug administration. The cochlear tissue was assessed in all groups by histopathologic, immunohistochemical and TUNEL assay. In addition, serum oxidative stress markers and antioxidant parameters were analyzed. Results There was a significant difference between the basal value and the sixth day at frequencies 8.4, 9.6 and 9.96 for group C. We also found a significant difference between the first and sixth day at frequencies 7.2, 8.4, 9.6 and 9.96. On the 6th day, there were significant differences between C and S groups at all frequencies except 2.4. We showed a significant difference between C and H groups at frequencies 4.8, 6.0, 8.4, 9.6 and 9.96. There was also a significant difference between C and CH groups at frequencies 2.4, and 3.6. We found lower levels of oxidants and higher levels of antioxidants in CH group as compared to C group. C group had a significantly greater number of TUNEL-positive cells than did S, H and CH groups. The number of TUNEL-positive cells in CH group was higher than in S and H groups. There was a significant difference between the positive PCNA cells of CH group compared to S and H groups in spiral ganglion and stria vascularis. In addition, there were no positive PCNA cells in C group. Conclusions Hesperetin may prevent ototoxicity by increased antioxidant enzymes and reduced oxidant parameters and protected against apoptosis resulting from a proliferation of cochlear cells in CIO.
- Published
- 2016
- Full Text
- View/download PDF